Company page

Liquidia Corporation

Liquidia Corporation, traded under the ticker LQDA, is a public company based in the United States with a market capitalization of approximately $7.67 billion. The company focuses on developing and commercializing innovative therapies for patients with serious diseases. Liquidia aims to improve treatment options and outcomes through its proprietary technologies.